Journal of International Oncology››2014,Vol. 41››Issue (10): 757-760.doi:10.3760/cma.j.issn.1673-422X.2014.10.012

Previous ArticlesNext Articles

Current status and advances of radiotherapy for limited-disease small cell lung cancer

HAN Dan, LI Bao-Sheng

  1. SixthDepartment ofRadiation Oncology,Shandong Cancer Hospital, School of Medicine and Life Science,University of Ji’nan-Shandong Academy of Medical Sciences,Ji’nan250117, China

  • Online:2014-10-29Published:2014-10-11
  • Contact:LI Bao-Sheng E-mail:baoshli@yahoo.com

Abstract:About30% ~40% ofsmallcelllungcancer(SCLC)patientsbelongtolimiteddisease (LD).Inthesettingoflimiteddiseasesmallcelllungcancer(LDSCLC),thecombinationofthoracicradio therapy(TRT)withchemotherapyisthestandardtreatmentforLDSCLCwithimprovedsurvivalandlocalcon trol.ItisproventhatprophylacticcranialirradiationcanimprovetheprognosisofpatientswithSCLC.Radio therapyshouldjoinintheearlychemotherapyandindividualizedformulateappropriatetargetvolume.Radiation schemesofconventionalfractionationorhyperfractionationwayarerecommended.

Key words:

margin-bottom: 0pt,text-indent: 24pt,line-height: 150%">Carcinoma,smallcell,Radiotherapy,Limiteddisease